Intravenous immunoglobulin prophylaxis for recurrent Stevens-Johnson syndrome.

J Am Acad Dermatol. 2004 Feb;50(2):286-8.
Hebert AA, Bogle MA.

Department of Dermatology, The University of Texas Health Science Center, Houston, Texas 77030, USA.

Human intravenous immunoglobulin has been described as a treatment for patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. We describe the prophylactic use of intravenous immunoglobulin to prevent Stevens-Johnson syndrome in a woman undergoing cardiac catheterization with a previous history of four episodes of Stevens-Johnson after receiving intravenous contrast dye.

Publication Types:
  • Case Reports

PMID: 14726889 [PubMed - indexed for MEDLINE]
Copyright © 2018 PPTA. All rights reserved. (202) 789-3100